Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
Clinical trial NCT01917630 · UNKNOWN
Trial details
- NCT number
- NCT01917630
- Sponsor
- Alvine Pharmaceuticals Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-04-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.